C.R. BARD, INC. (COVINGTON) -1018233

Manufacturer adverse-event records for C.R. BARD, INC. -1018233 come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2011–2026 · heavy-book · quiet Death-code · balanced

Volume signature

C.R. BARD, INC. -1018233 sits in the heavy MAUDE book

C.R. BARD, INC. (COVINGTON) -1018233 accounts for 47,321 FDA MAUDE reports (#78 of 443, heavy-book tercile). Death-coded event_type share is 0.06% (quiet); Injury share 16.0% (balanced).

What the volume reading shows for C.R. BARD, INC. (COVINGTON) -1018233

The standout signal for C.R. BARD, INC. (COVINGTON) -1018233 is filing volume: 47,321 adverse-event reports in FDA MAUDE (#78 of 443, heavy-book). Death-coded event_type share sits at 0.06% (quiet).

As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair C.R. BARD, INC. -1018233 with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.

Reports span 20 device types, led in this extract by Malfunction at 39,720 (83.9% of event_type total). Peak single-year volume reaches 7,026 reports across 16 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

47,321
Total Reports
30
Event-type Death
7,564
Injury Reports
20
Device Types

Event Types

Malfunction 39,720 (83.9%)
Injury 7,564 (16.0%)
Death 30 (0.1%)
Other 7 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Other 26,376 (55.1%)
16,057 (33.5%)
Required Intervention 4,529 (9.5%)
R 419 (0.9%)
Hospitalization 234 (0.5%)
O 158 (0.3%)
H 39 (0.1%)
Death 32 (0.1%)
Life Threatening 11 (0.0%)
S 8 (0.0%)
Disability 5 (0.0%)
L 4 (0.0%)
D 2 (0.0%)

Yearly Trend

11
2011: 2
12
2012: 34
13
2013: 355
14
2014: 32
15
2015: 64
16
2016: 170
17
2017: 3,582
18
2018: 4,742
19
2019: 6,090
20
2020: 6,137
21
2021: 6,571
22
2022: 7,026
23
2023: 5,777
24
2024: 4,034
25
2025: 2,701
26
2026: 4